200 related articles for article (PubMed ID: 29060933)
1. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
2. RNF4-mediated SUMOylation is essential for NDRG2 suppression of lung adenocarcinoma.
Tantai J; Pan X; Hu D
Oncotarget; 2016 May; 7(18):26837-43. PubMed ID: 27072586
[TBL] [Abstract][Full Text] [Related]
3. SENP3 regulates the global protein turnover and the Sp1 level via antagonizing SUMO2/3-targeted ubiquitination and degradation.
Wang M; Sang J; Ren Y; Liu K; Liu X; Zhang J; Wang H; Wang J; Orian A; Yang J; Yi J
Protein Cell; 2016 Jan; 7(1):63-77. PubMed ID: 26511642
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
5. SENP2 suppresses epithelial-mesenchymal transition of bladder cancer cells through deSUMOylation of TGF-βRI.
Tan M; Zhang D; Zhang E; Xu D; Liu Z; Qiu J; Fan Y; Shen B
Mol Carcinog; 2017 Oct; 56(10):2332-2341. PubMed ID: 28574613
[TBL] [Abstract][Full Text] [Related]
6. SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1.
Song JG; Xie HH; Li N; Wu K; Qiu JG; Shen DM; Huang CJ
Tumour Biol; 2015 Dec; 36(12):9865-71. PubMed ID: 26164001
[TBL] [Abstract][Full Text] [Related]
7. The E3 ligase APC/C-Cdh1 regulates MEF2A-dependent transcription by targeting SUMO-specific protease 2 for ubiquitination and degradation.
Lu H; Liu B; Zhang FJ; Zhang J; Dong R; Chen L; Qu DM; Lu Y; Yu BW
Cell Cycle; 2014; 13(24):3892-902. PubMed ID: 25483061
[TBL] [Abstract][Full Text] [Related]
8. SUMO-specific protease 2 suppresses cell migration and invasion through inhibiting the expression of MMP13 in bladder cancer cells.
Tan MY; Mu XY; Liu B; Wang Y; Bao ED; Qiu JX; Fan Y
Cell Physiol Biochem; 2013; 32(3):542-8. PubMed ID: 24008762
[TBL] [Abstract][Full Text] [Related]
9. SENP2 regulated the stability of β-catenin through WWOX in hepatocellular carcinoma cell.
Jiang QF; Tian YW; Shen Q; Xue HZ; Li K
Tumour Biol; 2014 Oct; 35(10):9677-82. PubMed ID: 24969559
[TBL] [Abstract][Full Text] [Related]
10. SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation.
Ran Y; Liu TT; Zhou Q; Li S; Mao AP; Li Y; Liu LJ; Cheng JK; Shu HB
J Mol Cell Biol; 2011 Oct; 3(5):283-92. PubMed ID: 22028379
[TBL] [Abstract][Full Text] [Related]
11. SUMO-specific protease 2 (SENP2) suppresses keratinocyte migration by targeting NDR1 for de-SUMOylation.
Xiao N; Li H; Yu W; Gu C; Fang H; Peng Y; Mao H; Fang Y; Ni W; Yao M
FASEB J; 2019 Jan; 33(1):163-174. PubMed ID: 29969578
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
[TBL] [Abstract][Full Text] [Related]
13. Enhanced desumoylation in murine hearts by overexpressed SENP2 leads to congenital heart defects and cardiac dysfunction.
Kim EY; Chen L; Ma Y; Yu W; Chang J; Moskowitz IP; Wang J
J Mol Cell Cardiol; 2012 Mar; 52(3):638-49. PubMed ID: 22155005
[TBL] [Abstract][Full Text] [Related]
14. SUMO1/sentrin/SMT3 specific peptidase 2 modulates target molecules and its corresponding functions.
Liu SL; Gao FH
Biochimie; 2018 Sep; 152():6-13. PubMed ID: 29908207
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of SENP2-mediated Akt deSUMOylation promotes cardiac regeneration via activating Akt pathway.
Chen Y; Xu T; Li M; Li C; Ma Y; Chen G; Sun Y; Zheng H; Wu G; Liao W; Liao Y; Chen Y; Bin J
Clin Sci (Lond); 2021 Mar; 135(6):811-828. PubMed ID: 33687053
[TBL] [Abstract][Full Text] [Related]
16. Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death.
Choi SC; Yoon SR; Park YP; Song EY; Kim JW; Kim WH; Yang Y; Lim JS; Lee HG
Exp Mol Med; 2007 Dec; 39(6):705-14. PubMed ID: 18160841
[TBL] [Abstract][Full Text] [Related]
17. SENP2 regulates hepatocellular carcinoma cell growth by modulating the stability of β-catenin.
Shen HJ; Zhu HY; Yang C; Ji F
Asian Pac J Cancer Prev; 2012; 13(8):3583-7. PubMed ID: 23098437
[TBL] [Abstract][Full Text] [Related]
18. SENP2 regulates MMP13 expression in a bladder cancer cell line through SUMOylation of TBL1/TBLR1.
Tan M; Gong H; Wang J; Tao L; Xu D; Bao E; Liu Z; Qiu J
Sci Rep; 2015 Sep; 5():13996. PubMed ID: 26369384
[TBL] [Abstract][Full Text] [Related]
19. The SUMO-Specific Protease Senp2 Regulates SUMOylation, Expression and Function of Human Organic Anion Transporter 3.
Wang H; You G
Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1293-1301. PubMed ID: 31054272
[TBL] [Abstract][Full Text] [Related]
20. The deSUMOylase SENP2 coordinates homologous recombination and nonhomologous end joining by independent mechanisms.
Garvin AJ; Walker AK; Densham RM; Chauhan AS; Stone HR; Mackay HL; Jamshad M; Starowicz K; Daza-Martin M; Ronson GE; Lanz AJ; Beesley JF; Morris JR
Genes Dev; 2019 Mar; 33(5-6):333-347. PubMed ID: 30796017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
